442 related articles for article (PubMed ID: 16966509)
1. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
[TBL] [Abstract][Full Text] [Related]
2. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
[TBL] [Abstract][Full Text] [Related]
3. Thalamic atrophy and cognition in multiple sclerosis.
Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
[TBL] [Abstract][Full Text] [Related]
4. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
[TBL] [Abstract][Full Text] [Related]
5. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
Portaccio E; Amato MP; Bartolozzi ML; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
J Neurol Sci; 2006 Jun; 245(1-2):195-9. PubMed ID: 16631794
[TBL] [Abstract][Full Text] [Related]
6. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis.
Tekok-Kilic A; Benedict RH; Weinstock-Guttman B; Dwyer MG; Carone D; Srinivasaraghavan B; Yella V; Abdelrahman N; Munschauer F; Bakshi R; Zivadinov R
Neuroimage; 2007 Jul; 36(4):1294-300. PubMed ID: 17524670
[TBL] [Abstract][Full Text] [Related]
7. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
Tiemann L; Penner IK; Haupts M; Schlegel U; Calabrese P
Mult Scler; 2009 Oct; 15(10):1164-74. PubMed ID: 19667010
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
9. Cortical atrophy and personality in multiple sclerosis.
Benedict RH; Hussein S; Englert J; Dwyer MG; Abdelrahman N; Cox JL; Munschauer FE; Weinstock-Guttman B; Zivadinov R
Neuropsychology; 2008 Jul; 22(4):432-41. PubMed ID: 18590355
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
[TBL] [Abstract][Full Text] [Related]
11. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
Benedict RH; Carone DA; Bakshi R
J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
[TBL] [Abstract][Full Text] [Related]
12. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
13. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis.
Mesaros S; Rovaris M; Pagani E; Pulizzi A; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Martinelli V; Comi G; Filippi M
Arch Neurol; 2008 Sep; 65(9):1223-30. PubMed ID: 18779427
[TBL] [Abstract][Full Text] [Related]
14. Active cognitive reserve influences the regional atrophy to cognition link in multiple sclerosis.
Booth AJ; Rodgers JD; Schwartz CE; Quaranto BR; Weinstock-Guttman B; Zivadinov R; Benedict RH
J Int Neuropsychol Soc; 2013 Nov; 19(10):1128-33. PubMed ID: 24050681
[TBL] [Abstract][Full Text] [Related]
15. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
Benedict RH; Bruce J; Dwyer MG; Weinstock-Guttman B; Tjoa C; Tavazzi E; Munschauer FE; Zivadinov R
Mult Scler; 2007 Jul; 13(6):722-30. PubMed ID: 17613599
[TBL] [Abstract][Full Text] [Related]
17. Regional hippocampal atrophy in multiple sclerosis.
Sicotte NL; Kern KC; Giesser BS; Arshanapalli A; Schultz A; Montag M; Wang H; Bookheimer SY
Brain; 2008 Apr; 131(Pt 4):1134-41. PubMed ID: 18375977
[TBL] [Abstract][Full Text] [Related]
18. Predicting neuropsychological abnormalities in multiple sclerosis.
Benedict RH; Zivadinov R
J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
[TBL] [Abstract][Full Text] [Related]
19. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
[TBL] [Abstract][Full Text] [Related]
20. Validation of linear cerebral atrophy markers in multiple sclerosis.
Butzkueven H; Kolbe SC; Jolley DJ; Brown JY; Cook MJ; van der Mei IA; Groom PS; Carey J; Eckholdt J; Rubio JP; Taylor BV; Mitchell PJ; Egan GF; Kilpatrick TJ
J Clin Neurosci; 2008 Feb; 15(2):130-7. PubMed ID: 18068987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
